Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Publication date

2015

Authors

Ahmadizar, F.ISNI 000000041957475X
Onland-Moret, N Charlotte
De Boer, AnthoniusISNI 0000000389596105
Liu, Geoffrey
Maitland-Van der Zee, Anke-HilseISNI 0000000376188831

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Keywords

SDG 3 - Good Health and Well-being

Citation

Ahmadizar, F, Onland-Moret, N C, de Boer, A, Liu, G & Maitland-van der Zee, A H 2015, 'Correction : Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', PLoS One, vol. 10, no. 10, pp. e0141704. https://doi.org/10.1371/journal.pone.0141704